Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OptumRx Inc.

Division of UnitedHealth Group Co.
www.optumrx.com

Latest From OptumRx Inc.

Express Scripts Could Negotiate Drug Rebates For 100m Lives With Prime Therapeutics Deal

Manufacturers will face the “biggest PBM ever” in price negotiations for pharmacy benefit drugs as a result of the collaboration between the two pharmacy benefit managers.

Pharmacy Benefit Management Reimbursement

Teva Seeks Global Resolution Of Opioid Litigation

Teva and three distributors settle with two plaintiffs; PBMs are defendants in next case as Teva also reaches an agreement in principal with four attorneys general for global settlement framework.

Legal Issues Strategy

Teva Seeks Global Resolution Of Opioid Litigation As Bellwether Trial Is Halted

Teva and three distributors settle with two plaintiffs; PBMs are defendants in next case as Teva also reaches an agreement in principal with four attorneys general for global settlement framework. 

Legal Issues Advertising, Marketing & Sales

Label Battles: Beovu And Eylea Contest Begins In AMD

Shares in Eylea-maker Regeneron slid after FDA approved Novartis's competing VEGF inhibitor for treating AMD, but some observers said investors had overreacted.

Commercial Companies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Prescription Solutions
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • UnitedHealth Group Co.
  • Senior Management
  • Timothy Wicks, CEO
    Jeffrey Grosklags, CFO
  • Contact Info
  • OptumRx Inc.
    Phone: (800) 788-4863
    2300 Main St.
    Irvine, CA 92614
    USA
UsernamePublicRestriction

Register